Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,358 | 277 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $541.98 | 37 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $443.37 | 6 | $0 (2021) |
| Esperion Therapeutics, Inc. | $372.69 | 26 | $0 (2022) |
| Amgen Inc. | $351.81 | 26 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $260.14 | 17 | $0 (2021) |
| Novo Nordisk Inc | $254.78 | 12 | $0 (2022) |
| GlaxoSmithKline, LLC. | $228.40 | 18 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $216.98 | 16 | $0 (2022) |
| Lilly USA, LLC | $207.69 | 15 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $197.49 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $351.39 | 22 | ABBVIE INC. ($73.55) |
| 2021 | $4,007 | 255 | AbbVie Inc. ($468.43) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Gastroenterology | ||||||
| 02/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/01/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/28/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.87 | General |
| 01/27/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: PSYCHIATRY | ||||||
| 01/27/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Inflammation | ||||||
| 01/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: PRIMARY CARE | ||||||
| 01/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: DIABETES | ||||||
| 01/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/19/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardio-renal | ||||||
| 01/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: DIABETES | ||||||
| 01/11/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PRIMARY CARE | ||||||
| 01/11/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/07/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/06/2022 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Neuroscience | ||||||
| 01/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/21/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/21/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 118 | 123 | $12,110 | $7,557 |
| 2022 | 6 | 185 | 195 | $23,395 | $7,758 |
| 2021 | 17 | 1,111 | 1,522 | $170,825 | $77,634 |
| 2020 | 15 | 823 | 1,264 | $31,835 | $13,976 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 19 | 19 | $2,660 | $2,441 | 91.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 28 | $3,220 | $1,307 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $2,774 | $1,299 | 46.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $2,196 | $1,295 | 59.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $760.00 | $724.28 | 95.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $500.00 | $490.00 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 60 | $6,804 | $2,549 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 65 | $10,898 | $1,841 | 16.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $2,074 | $1,165 | 56.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $2,044 | $1,044 | 51.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 20 | $1,100 | $692.76 | 63.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $475.00 | $465.50 | 98.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 245 | 492 | $82,656 | $37,112 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 188 | 267 | $29,904 | $13,835 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $14,040 | $8,309 | 59.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 93 | 93 | $12,183 | $5,219 | 42.8% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 44 | 44 | $7,480 | $2,731 | 36.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 18 | 18 | $4,680 | $2,468 | 52.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $5,742 | $2,162 | 37.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 66 | 96 | $4,400 | $2,106 | 47.9% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2021 | 56 | 56 | $1,680 | $780.69 | 46.5% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 43 | 61 | $1,403 | $775.92 | 55.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 50 | 50 | $1,714 | $743.00 | 43.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 39 | 62 | $2,232 | $502.15 | 22.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 47 | 47 | $498.20 | $292.81 | 58.8% |
About Amy Thomas, APRN
Amy Thomas, APRN is a Family healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1205227071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Thomas, APRN has received a total of $4,358 in payments from pharmaceutical and medical device companies, with $351.39 received in 2022. These payments were reported across 277 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,358).
As a Medicare-enrolled provider, Thomas has provided services to 2,237 Medicare beneficiaries, totaling 3,104 services with total Medicare billing of $106,925. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Elizabethtown, KY
- Active Since 02/13/2015
- Last Updated 03/28/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205227071
Products in Payments
- BREZTRI (Drug) $402.89
- NEXLETOL (Drug) $352.58
- NURTEC ODT (Drug) $313.83
- VRAYLAR (Drug) $228.04
- TRELEGY ELLIPTA (Drug) $227.11
- Ozempic (Drug) $211.51
- SOLIQUA 100/33 (Biological) $170.50
- ENTRESTO (Drug) $165.71
- Aimovig (Biological) $142.04
- UBRELVY (Drug) $137.46
- XARELTO (Drug) $130.79
- HETLIOZ (Drug) $123.81
- EVENITY (Biological) $109.44
- Otezla (Drug) $100.33
- REXULTI (Drug) $98.66
- STIOLTO RESPIMAT (Drug) $92.48
- TRULICITY (Drug) $89.97
- JARDIANCE (Drug) $89.61
- COLOGUARD DNA CAPTURE REAGENTS (Device) $87.86
- LINZESS (Drug) $83.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Elizabethtown
Mrs. Ashley Snellen, Msn, Fnp, MSN, FNP
Family — Payments: $128,264
Mrs. Gwendolynn Thomas, Aprn, APRN
Family — Payments: $9,849
Mr. Shaun Milby, Aprn, APRN
Family — Payments: $7,551
Mrs. Brooke Taylor, Arnp, ARNP
Family — Payments: $4,888
Kasey Kindervater, Aprn, APRN
Family — Payments: $4,651
Misty Gilley, Fnp, FNP
Family — Payments: $4,413